GOSS
Price
$2.55
Change
-$0.11 (-4.14%)
Updated
Jan 14 closing price
Capitalization
590.21M
57 days until earnings call
Intraday BUY SELL Signals
SGMT
Price
$6.37
Change
+$0.16 (+2.58%)
Updated
Jan 14 closing price
Capitalization
207.16M
74 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

GOSS vs SGMT

Header iconGOSS vs SGMT Comparison
Open Charts GOSS vs SGMTBanner chart's image
Gossamer Bio
Price$2.55
Change-$0.11 (-4.14%)
Volume$3.51M
Capitalization590.21M
Sagimet Biosciences
Price$6.37
Change+$0.16 (+2.58%)
Volume$698.08K
Capitalization207.16M
GOSS vs SGMT Comparison Chart in %
GOSS
Daily Signal:
Gain/Loss:
SGMT
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
GOSS vs. SGMT commentary
Jan 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GOSS is a Hold and SGMT is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 15, 2026
Stock price -- (GOSS: $2.55 vs. SGMT: $6.37)
Brand notoriety: GOSS and SGMT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GOSS: 87% vs. SGMT: 119%
Market capitalization -- GOSS: $590.21M vs. SGMT: $207.16M
GOSS [@Biotechnology] is valued at $590.21M. SGMT’s [@Biotechnology] market capitalization is $207.16M. The market cap for tickers in the [@Biotechnology] industry ranges from $114.05B to $0. The average market capitalization across the [@Biotechnology] industry is $2.27B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GOSS’s FA Score shows that 0 FA rating(s) are green whileSGMT’s FA Score has 1 green FA rating(s).

  • GOSS’s FA Score: 0 green, 5 red.
  • SGMT’s FA Score: 1 green, 4 red.
According to our system of comparison, GOSS is a better buy in the long-term than SGMT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GOSS’s TA Score shows that 4 TA indicator(s) are bullish while SGMT’s TA Score has 5 bullish TA indicator(s).

  • GOSS’s TA Score: 4 bullish, 6 bearish.
  • SGMT’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, SGMT is a better buy in the short-term than GOSS.

Price Growth

GOSS (@Biotechnology) experienced а +5.81% price change this week, while SGMT (@Biotechnology) price change was +15.40% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.31%. For the same industry, the average monthly price growth was +3.20%, and the average quarterly price growth was +43.69%.

Reported Earning Dates

GOSS is expected to report earnings on Mar 13, 2026.

SGMT is expected to report earnings on Mar 30, 2026.

Industries' Descriptions

@Biotechnology (+0.31% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GOSS($590M) has a higher market cap than SGMT($207M). SGMT YTD gains are higher at: 7.601 vs. GOSS (-17.742). SGMT has higher annual earnings (EBITDA): -64.32M vs. GOSS (-145.74M). GOSS has more cash in the bank: 180M vs. SGMT (117M). SGMT has less debt than GOSS: SGMT (115K) vs GOSS (203M). GOSS has higher revenues than SGMT: GOSS (44.1M) vs SGMT (0).
GOSSSGMTGOSS / SGMT
Capitalization590M207M285%
EBITDA-145.74M-64.32M227%
Gain YTD-17.7427.601-233%
P/E RatioN/AN/A-
Revenue44.1M0-
Total Cash180M117M154%
Total Debt203M115K176,522%
FUNDAMENTALS RATINGS
GOSS: Fundamental Ratings
GOSS
OUTLOOK RATING
1..100
73
VALUATION
overvalued / fair valued / undervalued
1..100
44
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
43
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GOSSSGMT
RSI
ODDS (%)
Bullish Trend 3 days ago
68%
Bullish Trend 1 day ago
87%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
77%
Bearish Trend 1 day ago
84%
Momentum
ODDS (%)
Bearish Trend 3 days ago
88%
Bullish Trend 1 day ago
85%
MACD
ODDS (%)
Bearish Trend 3 days ago
84%
Bullish Trend 1 day ago
83%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
85%
Bullish Trend 1 day ago
84%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
89%
Bullish Trend 1 day ago
88%
Advances
ODDS (%)
Bullish Trend 3 days ago
85%
Bullish Trend 4 days ago
85%
Declines
ODDS (%)
Bearish Trend 9 days ago
87%
Bearish Trend 17 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
89%
Bullish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
78%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
GOSS
Daily Signal:
Gain/Loss:
SGMT
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EDESY19.15N/A
N/A
Elders Ltd
COLDF0.17N/A
N/A
Cardno Ltd.
SNZZF0.54N/A
N/A
Senzime AB
PGPHF1222.08-79.90
-6.14%
Partners Group Holding Zug Namen-Akt
ABZPF0.58-0.22
-27.55%
Aboitiz Power Corp.

GOSS and

Correlation & Price change

A.I.dvisor indicates that over the last year, GOSS has been loosely correlated with LITS. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if GOSS jumps, then LITS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GOSS
1D Price
Change %
GOSS100%
-4.14%
LITS - GOSS
46%
Loosely correlated
+4.03%
APVO - GOSS
41%
Loosely correlated
+1.41%
ABEO - GOSS
40%
Loosely correlated
+1.96%
XNCR - GOSS
39%
Loosely correlated
+3.66%
SYRE - GOSS
39%
Loosely correlated
+5.17%
More

SGMT and

Correlation & Price change

A.I.dvisor indicates that over the last year, SGMT has been loosely correlated with NGNE. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if SGMT jumps, then NGNE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SGMT
1D Price
Change %
SGMT100%
+2.58%
NGNE - SGMT
40%
Loosely correlated
+10.91%
SYRE - SGMT
38%
Loosely correlated
+5.17%
FTRE - SGMT
36%
Loosely correlated
-3.45%
CGON - SGMT
36%
Loosely correlated
+5.57%
GOSS - SGMT
36%
Loosely correlated
-4.14%
More